U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C8H4N4O6
Molecular Weight 252.1406
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FG-9041

SMILES

[O-][N+](=O)C1=CC2=C(NC(=O)C(=O)N2)C=C1[N+]([O-])=O

InChI

InChIKey=RWVIMCIPOAXUDG-UHFFFAOYSA-N
InChI=1S/C8H4N4O6/c13-7-8(14)10-4-2-6(12(17)18)5(11(15)16)1-3(4)9-7/h1-2H,(H,9,13)(H,10,14)

HIDE SMILES / InChI

Molecular Formula C8H4N4O6
Molecular Weight 252.1406
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

FG-9041 (6,7-Dinitroquinoxaline-2,3-dion or DNQX) is an antagonist of non-NMDA glutamate (AMPA and kainate) receptor. FG-9041 is used in molecular biology to identify the properties of different types of channels. In addition, experiments in rats have shown that DNQX reduces electroconvulsive shock-induced impairment of learning-memory.

Approval Year

Targets

Targets

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Contribution of ionotropic glutamate receptors to acute amphetamine-stimulated preproenkephalin mRNA expression in the rat striatum in vivo.
2003 Jul 31
Diphenyl ditelluride induces hypophosphorylation of intermediate filaments through modulation of DARPP-32-dependent pathways in cerebral cortex of young rats.
2012 Feb
Patents

Patents

Sample Use Guides

Forty-eight adult Wistar-Kyoto (WKY) rats (an animal model for depressive behavior): DNQX (FG9041) (iv 2 mL 5 mg/kg DNQX through the tail veins of WKY rats )
Route of Administration: Intravenous
It was tested the effects of the quinoxaline derivative DNQX (FG9041) on the membrane potential of thalamic reticular nucleus (TRN) and ventrobasal (VB) neurons. DNQX (20 μM) produced a slow-onset, long-duration depolarization in all TRN neurons tested with average amplitude of 3.3 ± 1.1 mV. In contrast, DNQX (20 μM) did not alter the membrane potential (0.2 ± 0.5 mV, n = 6) or input resistance of VB neurons. Accordingly, in voltage-clamp recordings, DNQX (20 μM) evoked an inward current that averaged −14.3 ± 5.6 pA but not in VB neurons (1.3 ± 2.3 pA, n = 5, P > 0.1). At a lower concentration, DNQX (4 μM) produced a negligible depolarization (0.3 ± 0.3 mV, n = 5) in TRN neurons, but at higher concentrations, DNQX (100 μM) produced a larger depolarization that averaged 3.7 ± 1.6 mV.
Substance Class Chemical
Created
by admin
on Mon Mar 31 23:04:31 GMT 2025
Edited
by admin
on Mon Mar 31 23:04:31 GMT 2025
Record UNII
62T278S1MX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FG-9041
Common Name English
DNQX
Preferred Name English
6,7-DINITROQUINOXALINE-2,3-DIONE
Systematic Name English
2,3-QUINOXALINEDIONE, 1,4-DIHYDRO-6,7-DINITRO-
Systematic Name English
Code System Code Type Description
PUBCHEM
3899541
Created by admin on Mon Mar 31 23:04:31 GMT 2025 , Edited by admin on Mon Mar 31 23:04:31 GMT 2025
PRIMARY
FDA UNII
62T278S1MX
Created by admin on Mon Mar 31 23:04:31 GMT 2025 , Edited by admin on Mon Mar 31 23:04:31 GMT 2025
PRIMARY
CAS
2379-57-9
Created by admin on Mon Mar 31 23:04:31 GMT 2025 , Edited by admin on Mon Mar 31 23:04:31 GMT 2025
PRIMARY
EPA CompTox
DTXSID60178476
Created by admin on Mon Mar 31 23:04:31 GMT 2025 , Edited by admin on Mon Mar 31 23:04:31 GMT 2025
PRIMARY
DRUG BANK
DB03759
Created by admin on Mon Mar 31 23:04:31 GMT 2025 , Edited by admin on Mon Mar 31 23:04:31 GMT 2025
PRIMARY
WIKIPEDIA
DNQX
Created by admin on Mon Mar 31 23:04:31 GMT 2025 , Edited by admin on Mon Mar 31 23:04:31 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY